Hemorrhagic Septicemia in Cattle and Buffalo

Hemorrhagic septicemia (HS) represents a severe, rapidly progressing bacterial infection that poses a significant risk to cattle and water buffalo, particularly in tropical and subtropical regions of Asia and Africa. Caused by specific strains of Pasteurella multocida, this disease leads to high mortality rates, often exceeding 90% in untreated outbreaks, making it a critical concern for livestock farmers and veterinarians worldwide.

The Pathogen Behind the Disease

At the core of HS is Pasteurella multocida, a gram-negative bacterium belonging to serotypes B:2 and E:2. These serotypes possess a thick polysaccharide capsule that enhances their virulence by evading the host’s immune defenses and promoting rapid bacterial multiplication in tissues. The capsule also contributes to the formation of characteristic edematous swellings observed in affected animals.

This pathogen typically resides asymptomatically in the upper respiratory tract of carrier animals, such as healthy cattle or buffalo. Under normal conditions, it remains dormant, but environmental or physiological stressors trigger its proliferation and dissemination. Unlike other P. multocida strains that cause milder respiratory issues, HS serotypes are uniquely adapted for systemic invasion, leading to bacteremia and endotoxemia.

Factors Triggering Outbreaks

Outbreaks of HS are closely linked to multiple stressors that compromise animal immunity. High ambient temperatures combined with elevated humidity, especially during rainy seasons, create ideal conditions for bacterial survival in the environment. Contaminated water sources and feed prolong the viability of the organism outside the host.

Additional triggers include concurrent infections like foot-and-mouth disease or blood parasites, nutritional deficiencies, and physical exertion from work or transport. In endemic zones, young adults and older calves are most vulnerable, while naive populations in non-endemic areas face near-total mortality during epizootics. Water buffalo consistently show higher susceptibility and severity compared to cattle, likely due to genetic predispositions.

• Key environmental stressors: Excessive rainfall, poor ventilation in housing.
• Host-related factors: Malnutrition, overworking, co-infections.
• Seasonal patterns: Peak incidence in monsoon periods due to prolonged bacterial persistence.

Transmission Dynamics

Infection spreads primarily through direct contact with respiratory secretions from carriers or clinically ill animals. Ingestion of contaminated fodder or water serves as another common route, with bacteria initially colonizing the tonsils and nasopharynx. From there, they enter the bloodstream, causing widespread dissemination.

The incubation period ranges from 1 to 3 days, after which clinical signs emerge abruptly. In carrier animals, stress-induced shedding amplifies transmission within herds. Unlike airborne spread, HS relies on close contact or fomites, emphasizing the role of biosecurity in prevention.

Recognizing Clinical Manifestations

HS manifests in peracute, acute, or subclinical forms, with peracute cases proving most lethal. Animals succumb within 8-24 hours, often displaying high fever (up to 106°F or 41.1°C), profuse salivation, serous nasal discharge, and respiratory distress. These signs may go unnoticed due to the disease’s swift progression.

In acute cases lasting 2-5 days, symptoms intensify: apathy, reluctance to move, lacrimation, progression to mucopurulent nasal discharge, and marked subcutaneous edema in the throat, neck, and brisket regions. Respiratory compromise leads to cyanosis, frothy nasal discharge, recumbency, and occasionally diarrhea or abdominal discomfort. Buffalo exhibit more pronounced edema and faster deterioration.

Pathological Changes in Affected Animals

Post-mortem examinations reveal hallmark lesions: gelatinous edema in the submandibular, cervical, and brisket areas, often blood-tinged. Widespread hemorrhages appear as petechiae and ecchymoses on serosal surfaces, particularly in lungs, heart, gastrointestinal tract, and urinary organs. Lymph nodes, especially pharyngeal and cervical, show pronounced congestion.

Other findings include hydropericardium, pleural and peritoneal effusions, pulmonary edema with possible pneumonia, and gastroenteritis. Adrenal glands and abomasum may exhibit severe hemorrhages. These changes underscore the endotoxemic nature of HS, driven by lipopolysaccharide release triggering cytokine storms.

Diagnostic Approaches

In endemic areas, presumptive diagnosis relies on history, season, vaccination status, and pathognomonic signs like throat swelling. Differentials include anthrax, salmonellosis, blackleg, or toxicities. Laboratory confirmation involves isolating P. multocida B:2/E:2 from blood, tissues, or swabs via culture, alongside PCR for capsular typing.

Post-mortem sampling targets edematous fluid, lymph nodes, and lung tissue. Serological tests detect antibodies but are less useful acutely. Molecular assays provide rapid, specific identification, crucial for outbreak confirmation.

Treatment Strategies for Survival

Success hinges on early intervention, ideally within hours of onset. Intravenous antibiotics like penicillin, oxytetracycline, or ceftiofur target the bacterium effectively if administered promptly. Supportive care includes anti-inflammatories for edema, fluids for dehydration, and isolation to curb spread.

However, peracute cases often progress too rapidly for treatment. Survivors may develop immunity to homologous strains but can become carriers. Mass prophylaxis with long-acting antibiotics during outbreaks limits further losses in high-risk herds.

Prevention Through Vaccination and Management

Vaccination forms the cornerstone of control, using alum-precipitated or oil-adjuvant vaccines incorporating regional strains. Annual boosters before high-risk seasons (e.g., monsoons) are recommended, targeting calves from 6 months. Efficacy varies (60-90%), influenced by strain matching and cold chain maintenance.

• Vaccine types: Inactivated bacterins, sometimes combined with other antigens.
• Schedule: Initial dose at 6-8 months, annual revaccination.
• Limitations: Cross-protection not always complete; field trials show variable results.

Biosecurity measures—quarantine, stress reduction, improved nutrition, and sanitation—complement vaccination. Avoid mixing carriers with naive animals and ensure clean water sources.

Economic and Global Impact

HS inflicts substantial losses in developing countries, with epizootics wiping out entire herds. In Asia, where buffalo are vital for draft power and milk, outbreaks disrupt rural economies. Global surveillance by organizations like WOAH aids in strain monitoring and vaccine development.

Climate change may exacerbate risks through intensified rainy seasons, underscoring the need for resilient farming practices.

Frequently Asked Questions (FAQs)

What causes hemorrhagic septicemia?

HS is caused by Pasteurella multocida serotypes B:2 and E:2, triggered by stress in carrier animals.

Which animals are most affected?

Water buffalo and cattle in tropical regions; buffalo suffer more severely.

How can HS be prevented?

Through vaccination, stress management, and biosecurity protocols.

Is early treatment effective?

Yes, prompt IV antibiotics can save lives if given before advanced endotoxemia.

Can humans get HS from animals?

Rarely; only in immunocompromised individuals via direct contact with infected materials.